The new guidance, which can be found at www.rcvs.org.uk/coronavirus, will gradually replace the current emergency guidance and aims to help veterinary practices begin a phased return to near-normal operations:
Alongside the College’s guidance, the BVA is also publishing guidance for practices on working safely as lockdown restrictions are eased. [www.bva.co.uk/coronavirus/]
RCVS President Mandisa Greene said: “None of us could have predicted quite what an extraordinary and extraordinarily challenging 12 months this has been for everyone.
"On behalf of the whole of RCVS Council, I would like to thank sincerely once again all our veterinary and veterinary nursing colleagues, and all those in practice teams around the UK, for their awe-inspiring commitment, adaptability, resilience and sheer hard work in continuing to provide essential veterinary services and look after the health and welfare of the nation’s animals, in what have been the most difficult of times.
“Whilst I sincerely hope that we are at last beginning to see light at the end of the tunnel, if there is one thing we have learnt, it is that things can deteriorate rapidly if we don’t all continue to play our part and follow all relevant guidelines.
“I therefore urge my colleagues to continue to use their professional judgement and think very carefully about their gradual return to more normal working patterns over the coming weeks and months, according to their individual circumstances and the best interests of their teams, clients, and the animals they care for.”
RCVS Council has also agreed that the policy and guidance changes made in response to the pandemic over the past 12 months will now be reviewed, and decisions made as to whether to retain, amend or reverse them.
The article argues that as the equine influenza (EI) vaccine supply returns to normal, there is sound scientific evidence why bi-annual vaccination schedules should be re-implemented promptly.
Whilst the scale and number of outbreaks has been relatively small since the introduction of mandatory EI vaccination by most competitive equestrian disciplines in the 1980s, disease events such as those experienced in the UK in 1989, 2003 and most recently in 2019 have demonstrated EI’s epidemic potential, even in vaccinated horse populations.
In their article 'Equine influenza bi-annual boosters: what does the evidence tell us?' Victoria Colgate and Richard Newton discuss what has been learnt from previous outbreaks and explain the evidence from mathematical models to show why bi-annual boosters are beneficial.
The authors say that epidemiological data from previous natural EI outbreaks have repeatedly demonstrated the impermanent nature of the protection provided by vaccination and observational field studies have repeatedly highlighted the potential for 12-monthly boosters to leave a vulnerable immunity gap at both the individual animal and population level.
Mathematical models of EI transmission confirm that six-monthly rather than annual EI booster vaccinations are preferable to establish and maintain effective population level immunity to EI.
Ideally vaccine strains should be updated in a timely manner to ensure inclusion of the most epidemiologically-relevant strains, however, this is a slow and expensive process for equine vaccine manufacturers.
In the absence of updated vaccine strains, bi-annual vaccination is strongly recommended to help compensate for antigenic drift between vaccine and circulating EI viral strains
Professor Celia Marr, Editor of the EVJ said: “Although the recent EI vaccine shortage has necessitated a temporary relaxation of competition vaccine schedules, we must now renew the message that six-monthly boosters are optimal and necessary.”
The Editorial can be found at https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13898 and is free to view.
Two related articles can be found here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13874 and here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13885
The British Veterinary Association's Members' Services Group has devised a Vet Helpline sticker as a practical way to promote the help and support available to members of the veterinary profession suffering from anxiety or depression. It will be sent out with the 20th February edition of the Veterinary Record.
The suicide rate within the veterinary profession is around four times higher than in the general population and around twice that of other high risk groups including farmers and medical practitioners. Research has shown that long hours, the risk of professional mistakes and rising client expectation and administrative work lead to high levels of anxiety and depressive symptoms. Ready access to and knowledge of lethal means such as medicines and firearms may also be contributing factors in the increased suicide risk.
The Vet Helpline sticker acts as a constant reminder to veterinary professionals that a confidential helpline, manned by trained volunteers from the veterinary profession, is available around the clock on every day of the year to offer support and direct them to specialist help where appropriate. In addition to the Vet Helpline phone number the sticker also gives the number for the Samaritans and includes the address of the Vetlife website which is a "one stop shop" for all the help available.
BVA President, Professor Bill Reilly, said: "Please remember that if you're feeling depressed, lonely or under pressure, or are perhaps worried about a colleague, you can talk it over in confidence with trained volunteers from the veterinary profession. The Vet Helpline is there for all veterinary surgeons, nurses and students.
"Ours is a small profession and sadly most of us know someone who has suffered mental ill health or taken their own life. We hope that by reminding colleagues how to get help and continuing to publicise the Vetlife website and the Veterinary Benevolent Fund support services the BVA can play its part in supporting vets in crisis."
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.
All donations of unwanted clothes, books or bric-a-brac are sent for sale in one of the charity's 55 charity shops around the UK.
Working in partnership with National Veterinary Services (NVS), empty donation bags are given to veterinary practices to fill with goods for NVS to collect and deliver to the charity. The partnership with NVS began in 2011 and so far over 60,000 bags have been collected, with an estimated value of over £1m.
Mark Corbett, Head of Retail at Blue Cross said: "We are extremely grateful to NVS, the vet practices taking part in the scheme and their clients. Although the donated items may be unwanted possessions to some, each bag generates about £20 of income for us. This means the scheme has so far provided an incredible amount of income towards helping the pets in our care.
Blue Cross receives no government funding, so relies on public donations to continue its vital work.
Veterinary practices that receive their stock and drugs from NVS but are not yet part of The Blue Cross donation scheme can sign up now by contacting their NVS representative or email trading@bluecross.org.uk.
"Learning from everything – Significant Event Audits and root cause analysis" teaches how to use significant event auditing and root cause analysis tools to investigate an event and uncover what went wrong and what went right.
RCVS Knowledge says the boxset, with its supporting tools and templates, breaks down the steps from start to finish so that anyone in practice can use a tried and tested framework to reflect and share learning and contribute towards profession-wide improvements.
Pam Mosedale, Chair of the RCVS Knowledge Quality Improvement Advisory Board, said: “We all make mistakes; it’s how our teams deal with them and learn from them that is important.
“We understand that errors can be costly in practice, impacting our patients, causing stress for our teams, and financially impacting our businesses, and that is why we are providing practical free support for all veterinary teams.”
https://learn.rcvsknowledge.org/course/index.php?categoryid=4
Intervet/Schering-Plough Animal Health has announced the replacement of its Bovilis® IBR with Bovilis® IBR Marker Live vaccine, a move that brings the UK into line with the rest of Europe where marker vaccines are favoured.
Many EU member states, including Scandinavia and Austria are now declared IBR-free, and others (Germany and Hungary) operate national eradication programmes. Using a marker vaccine will help farmers wishing to export animals, or semen, or those working towards an eradication programme in their herds.
Recent bulk milk and blood screening via Intervet/Schering-Plough's complimentary BeefCheck and DairyCheck has revealed that 72% of herds tested were positive for IBR exposure. Given the latent nature of infection, and the rumbling losses associated with subclinical disease, it should come as no surprise that farmers are increasingly interested in controlling IBR. Studies have shown that IBR infection can result in a milk yield reduction of 173 litres per infected animal, or over £400 a year, for a 100-cow herd.
According to Intervet/Schering-Plough, Bovilis IBR Marker Live is Europe's leading IBR vaccine. It can be given intra-muscularly or intra-nasally to calves as young as two weeks old, as well as pregnant dams. It is also licensed to be given together with the pneumonia vaccine Bovilis® Bovipast RSP. The primary course involves one dose in cattle over three months of age, with immunity in just four days from the intra-nasal method, and 14 days from injection. Stock need re-vaccination every six months.
The vaccine reduces the amount of virus excreted into the environment, so minimising the risk to stressed cattle which may have been brought into the herd, and be latently infected. It also makes it an excellent choice for producers with breeding bulls, which should not be vaccinated. Bulls have to be kept naïve, however, the marker vaccine can be used on females in the herd to minimise virus circulation. This way the threat is minimised, and bulls can be kept infection free.
Before becoming a dragon, Jenny worked in banking for 30 years and will be sharing her experiences as an entrepreneur and business leader. She became CEO of cash machine company Hanco, bought out the business, turned it around and sold it for £50 million.
Jenny is supportive of the move to host BSAVA Congress online. She said: “Veterinary communities, like other professions, have seen the value that online technologies can offer, both for networking and socials, as well as essential CPD. We should all embrace these changes and look at the value that they can bring.”
The Congress programme is currently being finalised and the organisers say the emphasis is on ensuring the experience is an interactive as possible for each delegate. It will deliver more than 100 hours of CPD, delivered by globally recognised speakers.
BSAVA Congress 2021 Programme Committee Chair Andy Green said: ‘Whether a virtual or a live event our entire programme is proudly created by the profession, for the profession and we are committed to providing unrivalled education, with topical, clinically relevant and evidence-based content.”
There'll be a virtual commercial exhibition, where delegates will be able to chat with exhibitors from the comfort of their home or consult room. There will also be the ability to network with others in the profession, in face-to-face chat rooms. Professor Ian Ramsey, President of the BSAVA said: “BSAVA Congress 2021 is going to be one of the most innovative in the history of our events.
"While the pandemic circumstances we continue to find ourselves in are far from ideal, we must continue to evolve and progress as a profession. BSAVA Congress is a unique highlight in our calendar for next year and it is shaping up to be a truly memorable event."
For further information and to register your interest click here: https://www.bsavaevents.com/bsavacongress2021/en/page/home
Veterinary surgeons who want to pay in full must do so before before 1st June 2021. For those UK-practising vets who want to pay the fee in three instalments, the first payment should be received before 1st June, the second payment before 1st October and the final payment before the end of the year.
Any vets who do not pay either the fee in full or the first instalment before 1st June will be removed from the Register. If they want to be restored, they'll need to pay an additional restoration fee as well as the registration fee.
Professor Susan Dawson, RCVS Treasurer, said: “Due to the ongoing disruption to the profession because of the lockdown, we are glad to say that RCVS Council has again approved the ability for members of the profession to pay their fee in instalments and therefore spread the cost during this already difficult year.
"We would like to remind members of the profession that the option to pay in instalments is only available to UK-practising veterinary surgeons. For any UK-practising veterinary surgeons who have a Direct Debit set up but who wish to pay by instalments, please make sure to cancel your Direct Debit as soon as possible."
Payments can be made via the My Account area of the RCVS website (www.rcvs.org.uk/myaccount) where you will also need to confirm that you meet the annual continuing professional development (CPD) requirement and declare any convictions, cautions and/or adverse findings.
Any questions, contact the Registration Department: registration@rcvs.org.uk or 020 7202 0707.
For advice about making payments or submitting a remittance form, contact the Finance Department on finance@rcvs.org.uk or 020 7202 0723.
Further details about paying in instalments can also be found in a series of FAQs at: www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/retention-fee-faqs/
The three companies will now offer their services, which include marketing strategy, brand management, search engine marketing, online advertising, email marketing, webchat, social media copywriting, graphic design and web design under the VetsDigital brand.
Sarah Spinks, Managing Director of VetsDigital, said: "In the pursuit of better animal welfare, we empower animal owners, and bridge the gap between the veterinary professional and the pet parent using the most effective digital channels.
“As one combined company, we become Europe’s leading digital agency that specialises in the veterinary sector. With our current presence in 11 countries, we’ll be able to further develop our network whilst still providing our clients with the same personal service they’ve come to expect and deserve.”
Marcelo Alves, Managing Director of Vet Inflow, will move into the role of Managing Partner for Portugal and Spain at VetsDigital, as the company expands to have bases in both the UK and Portugal.
Will Stirling, who becomes a Managing Partner at VetsDigital, bringing with him 14 years of experience marketing in the veterinary industry, having previously worked with veterinary group YourVets and CVS, said: "The veterinary industry is buzzing with growth and renewal as many parts of veterinary marketing and management move into the digital realm. It’s the perfect time to combine the talents of our 3 teams, so that together we can offer industry-leading digital marketing services to veterinary businesses across the UK and Europe.
For more information, visit: https://vetsdigital.com
Vetoquinol has announced the launch of Chrysanphyton, the latest addition to its range of Equistro feeding stuffs for horses.
Vetoquinol says Chrysanphyton is recommended for horses where support of a normal blood flow to the hoof is important. It contains Chrysantellum americanum, blackcurrant and hazelnut extracts which, according to the company, provide a rich source of nutrient bioflavanoids and vitamins.
The recommended administration of Chrysanphyton is 10ml twice a day in horses (500kg) and 5ml twice a day in ponies with the 1000ml pack lasting 50 or 100 days respectively.
A product information sheet is available on the Equistro website www.equistro.co.uk
For further information contact your local Vétoquinol Territory Manager.
Improve International has launched 'Fast-Track' Postgraduate Certificate (PgC) Programmes, designed for veterinary surgeons who wish to take an immersive approach to study and complete the taught components in either its Small Animal Medicine or Small Animal Surgery programmes in three months.
The new programmes are set to begin in October 2015 with each able to accommodate a maximum of 12 delegates drawn from across Europe. In developing the content programme to suit a three month study period, Improve says it has added a range of features, including a dedicated mentor to support delegates.
The content for both the Small Animal Medicine and Small Animal Surgery Fast-Track PgC programmes is the same as the PgC programmes Improve runs over two years with the difference of the completion of the taught modules in three months. The programme then follows the normal PgC programme, with the completion of case reports, case studies and an examination, in order to gain a PgC. The Medicine PgC programme also includes additional practical sessions covering ophthalmology and diagnostic imaging, plus other core practical skills.
Practical training sessions for the Medicine Fast-Track programme will take place at Improve's Training Centre in Swindon while classroom-based sessions will be held at the Farmers' Club on the Embankment in Central London for ease of access. Delegates undertaking the Surgery programme will also be able to undertake practical sessions at Improve's facility at the John Krebs Field Station, Wytham, near Oxford. In addition to the tutored sessions, delegates on the Surgery programme will see practice with a subject expert for ten days, with the opportunity of scrubbing in to assist in soft tissue and orthopaedic surgical procedures.
To support delegates interested in the PgC Small Animal Medicine and Small Animal Surgery programmes, Improve has created a new website at www.vetpgc.co.uk.
David Babington MRCVS, Managing Director of Improve, said: "While vets generally take a PgC over a two year period in order to combine it with work commitments, there are circumstances in which it may be preferable to take some blocks of time out and complete the taught lectures in a shorter period of intensive study. Vets can be applying the new techniques in their practice after just three months and can gain a PgC in just one year.
"We wanted to offer this alternative study route to vets and have been working for some time to develop a consolidated three month version of both our Medicine and Surgery PgC training programmes. We're delighted to able to launch these exciting new programmes and look forward to welcoming our first cohort of delegates in October 2015."
For further information, visit www.vetpgc.co.uk or www.improveinternational.com or call 01793 759159.
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
The RVC says that until now, there has been little reliable evidence on the frequency and severity of syringomyelia in the overall dog population, which has limited veterinary surgeons’ ability to diagnose and manage the condition.
It's not just syringomyelia for which there is a lack of data. Scientists have for years struggled to identify the true extent and severity of diseases seen in the wider general dog population because the main source of veterinary health data on dogs has come from universities and referral hospitals.
While this referral data is useful, the types of animals and conditions that are referred to these referral centres is unrepresentative of the wider dog population, making it very difficult to extrapolate any findings to the general population. The vast majority of animals are managed perfectly well by the primary vet practitioners without ever being referred or even being ill at any one time.
However, through VetCompass, the RVC is now collecting anonymised clinical data from first opinion veterinary clinics across the UK; data which is being analysed to answer a wide variety of previously unanswerable health questions.
The VetCompass syringomyelia study published in the Veterinary Record is a case in point. It highlights for the first time the frequency and severity of syringomyelia seen in general practice in the UK.
At an overall dog population level, syringomyelia is not that common, affecting just one in 2,000 dogs. But among Cavaliers, the frequency of syringomyelia is much higher, affecting one in every 60 of the breed. VetCompass data reveals that almost 2,000 Cavaliers suffer from clinical syringomyelia in the UK at any one time.
Syringomyelia is a severe condition for affected dogs, with the VetCompass study showing that 72% of affected dogs were recorded as showing pain. The study showed that these dogs would often yelp or scream when they were picked up or when their necks were touched. Many of them also showed ‘phantom scratching’ where they would try to scratch at their necks with their hindlegs but without ever even making contact with the skin. Some people refer to this action as ‘playing an air guitar’.
The RVC is urging veterinary surgeons and owners alike to be aware of the symptoms of syringomyelia, so that clinically affected dogs can be recognised and treated earlier and better. Symptoms include:
Dr Dan O’Neill, Companion Animal Epidemiologist at the RVC, said: "I loved being a first opinion practice vet for over 20 years where I could help animals on a one-by-one basis. But now, with VetCompass, we can help animals by their thousands. An example is this syringomyelia study which may lead to many affected dogs getting treatment much earlier and therefore making their lives so much better."
Professor Holger Volk, Professor of Veterinary Neurology and Neurosurgery, said: “These VetCompass data are an eye-opener; we very frequently see Cavaliers with clinical signs of syringomyelia at RVC’s referral hospital but now we know how common it is in the real world, outside of the referral world."
Dr Ludovic Pelligand, Senior Lecturer in Clinical Pharmacology and Anaesthesia, said: “VetCompass allows us to identify how Cavalier King Charles affected by syringomyelia are treated for pain every day, nationwide. This will help us to understand optimal management and we are currently working on new ways to monitor pain and working towards developing new treatment options to further improve their pain relief and quality of life in the future".
The course offers veterinary surgeons and students six hours of CPD covering the five stages of EBVM and an overview of its evolution.
Users can progress through the six modules in order, or dip in and out of individual sections to deepen their knowledge in particular areas. The course includes a number of practical examples and quizzes, and there's a certificate of completion at the end.
The course can also be used as a reference tool for specific aspects of EBVM, such as how to search the literature effectively.
RCVS Knowledge says the new release of EBVM Learning has been well received by veterinary surgeons and nurses who helped test the course. Lucie Goodwin MRCVS said, simply: “This course is excellent.” Chris Gush, Executive Director of RCVS Knowledge (pictured right), said: “This fresh iteration of our EBVM Learning course is the culmination of a huge amount of committed work from an international network of leaders in EBVM, and we are proud to launch it on our new, accessible platform RCVS Knowledge Learn. The course constitutes an important way in which the charity supports all veterinary practitioners to advance the quality of care they provide through evidence-based veterinary medicine, regardless of their role, location or background.”
EBVM Learning can be accessed for free at http://learn.rcvsknowledge.org/ebvm-learning
The new Improve Veterinary Academy Series is comprised of five month-long semesters, each of which will focus on a different clinical topic.
Each semester will consist of videoed lectures, discussion forums, journal clubs, as well as the ability to access the university’s latest evidence-based research in these areas.
The clinical topics to be explored are:
Each semester counts towards your annual CPD requirement.
Professor James Wood, Head of the Department of Veterinary Medicine at University of Cambridge, said: “This new partnership will allow veterinary surgeons to get the latest evidence-based knowledge directly from our top specialists.
"They will also learn to apply valuable skills in their everyday practice life and engage with others on Improve International’s global, interactive online platform.
Charlotte French, Head of Curriculum & Quality at Improve International, said: “We are thrilled to be working with University of Cambridge Department of Veterinary Medicine as another innovative way to help the veterinary community take their careers to the next level.”
Professor Mike Herrtage, Trustee of the University of Cambridge Veterinary School Trust and former Dean of the Cambridge Veterinary School, said: “The new joint agreement brings together Improve International, with its outstanding record of high-quality and innovative CPD provision and the staff of the Department of Veterinary Medicine with their excellent specialist clinical knowledge and experience, as well as their recognised quality in small group teaching to stage the Improve International Academy Series.
"This will provide a new milestone in CPD course delivery.”
The event offers over 80 hours of CPD across seven streams – with everything from hypotension and sepsis to breaking bad news to clients – as well as world-renowned speakers and networking opportunities.
Søren Boysen from the University of Calgary in Canada and Sophie Adamantos from Paragon Referrals in Wakefield, are among several high-profile speakers at this year’s Congress.
Chief Executive for GB Snowsport, Victoria Gosling OBE, will open Congress as keynote speaker where she’ll focus on perseverance, resilience and teamwork.
Also speaking are Prof. John Williams, Richard Casey, executive director at the World Small Animal Veterinary Association and VDS trainer Elly Russell.
Arlene Connor, an RVN and head of clinical operations at Vets Now and IVC Evidensia has planned the programme alongside national ECC lead Dan Lewis (pictured right).
She said: “We’re so excited to be returning to the Royal Armouries for our 19th Vets Now ECC Congress – around a theme which celebrates us all being together again.
"The past two years have been a challenge for all of us in the veterinary professions and we hope to mitigate that with a return to face-to-face learning and networking, as well as the chance to have some fun.
"Events like this can be hugely inspirational — for the organisers as well as the attendees — and we truly can’t wait to welcome everyone through the doors like old times.”
Dan added: “There’s a brilliant line-up of live speakers, workshops, a packed exhibition hall and more opportunities than ever for delegates to meet old friends and make new ones, as well as to learn from some of the world’s leading veterinary experts discussing emergency and critical care.
“Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
Tickets range in price from £45 + VAT for exhibition-only tickets, up to £470 + VAT for a vet to attend for 2 days plus the Gala dinner.
To book your ticket, go to www.vets-now.com/congress2022
The programme offers a route to achieve a General Practitioner Certificate (GPCert).
In 14 modules (six online and eight face-to-face) delivered over 11 months, the programme covers the fundamental principles of the different imaging modalities, giving an overview of their application and benefits.
Each online module consists of four sessions spread over one month, with video lessons and case-based studies for learners to work through at their own pace.
There'll also be a monthly live webinar for case discussion and film reading sessions with the specialist tutor.
The face-to-face sessions are conducted over two consecutive days and are designed to support learners in consolidating their knowledge and developing skills in ultrasound.
As well as the GPCert, the course also offers a route to a Postgraduate Certificate (PgC) through the company’s partnership with Harper Adams University.
Programme registration includes a subscription to the RCVS Knowledge Library, which includes access to many electronic resources, including the latest journals and clinical research.
Head of Business Development for Improve International in the UK, Dr Charlotte French (pictured right), said: “The successful completion of this programme will increase learners’ skills, knowledge and confidence in dealing with more imaging cases, which will, in turn, enable them to grow their small animal caseload and revenue stream.
"With imaging so often a key element of a successful diagnosis, we are seeing increased interest from veterinary surgeons in upskilling in this fast-moving area and are delighted to offer them the opportunity to do this with our new programme.”
Bayer Animal Health has organised for prominent clinical microbiologist Dr Joseph Blondeau, from Canada's University of Saskatchewana, to tour the UK in May, giving talks to practitioners about effective antibiotic usage to prevent bacterial resistance.
Bayer's Technical Veterinary Adviser, Lucy Smith, will also be giving a talk: Maximise Treatment Success, which comes at the subject from the practical veterinary side.
Bayer Animal Health Marketing Manager, Dr Markus Edingloh said: "We are incredibly fortunate to work with such an eminent expert. Dr Blondeau is a leading authority on a new parameter that supports a dosing concept to minimise selection of bacterial resistance - the Mutant Prevention Concentration. Fortunately, he is also expert at presenting complex matters in an engaging and memorable way."
He added: "Lucy Smith will share her specific experience of Bayer's recently launched Veraflox (pradofloxacin), the first and only next generation veterinary fluoroquinolone, which has a broad spectrum of treatment which attacks Gram +, Gram - and anaerobic bacteria, in a highly efficacious way.
The evening events take place on: May 14th (Glasgow), May 15th (Derby), May 16th (Swindon) & May 17th (Surrey). Full details in the VetSurgeon Diary.
Each roadshow session is equivalent to 1.5 hours of free Continuing Professional Development (CPD).
To register to attend one of the roadshows, please email animal.health@bayer.com
Ian, who helped devise the PROTECT ME acronym which is now used worldwide to champion the cause of responsible antimicrobial use, said: "Antimicrobial resistance is one of the greatest threats of our time and it affects all sectors of the veterinary profession.
"While there will always remain a need for the use of antimicrobials for the treatment of bacterial infections, it is the duty of every one of us to continue our good work to protect their usage to ensure they remain effective for the future."
PROTECT ME stands for Prescribe only when necessary, Reduce prophylaxis, Offer other options, Treat effectively, Employ narrow spectrum, Cure appropriately, Tailor your practice policy. Monitor, Educate others.
Ian added: "I discussed the issue of restricted prescribing with my Doctor when he was treating my injury back in 2011
"Discussion on the Small Animal Medicine Society (SAMSOC) forum followed and then we developed a working group.
"I came up the name PROTECT when I was in the shower one day experimenting with acronyms on the shower cubicle wall!
"Collaboration with BSAVA enabled the scheme to launch in 2012 and then BEVA adapted the scheme and added the ME.”
PROTECT ME is now used for BSAVA and BEVA’s antimicrobial resources and campaigns and has also been taken up in New Zealand and been translated into French.
Rachael McGregor, Clinical Director at Calder Vets in Yorkshire asked Ian for help in developing antimicrobial stewardship guidelines for the practice last year. She said: “Ian helped us to set up prescribing guidelines using a traffic light system, supported a programme of CPD and supplied prescribing posters. This has made a significant difference to prescribing behaviour across the practice and over the past two months we haven’t prescribed a single critically important antibiotic.”
Davies has produced a range of resources for vets and for pet owners including an explanatory poster and a webinar series. For further information visit: https://vetspecialists.co.uk/insights/webinars/antimicrobial-webinars/
VetIT is launching a new suite of practice management software this month, which it claims will wipe out IT support worries while also giving vets secure access to their records wherever there's an internet connection.
Designed for practice-based and mobile vets, its developer says the near-universal access of the system will make VetIT ideal for the progressive and forward-thinking veterinary practice, particularly those with multiple locations. Early clients are already seeing the benefits of the system, which has been four years in development.
VetIT's Tony Houghton said: "The software offers practices a host of new features, all of them designed to increase usability, enhance revenue, reduce running costs and eliminate IT concerns. And because the new system has been developed in partnership with a well-established veterinary practice, VetIT sees and does things from a vet's perspective.
"During the development phase, our practice partner told us that existing packages were unwieldy - whether in their day-to-day operation, the ability to see and share data, or the 'back office' administration required. So we designed VetIT from scratch, to work in the most user-friendly manner."
According to Mr Houghton, the most significant difference is in how the software works - and in recognising that most practices expect IT systems to 'happen' in the background, rather than devouring precious time. "Existing packages are physically located in your practice - usually on a dedicated server, requiring daily back-ups and maintenance.
"VetIT, conversely, is a 'web-hosted solution' - like Sage Online or for that matter, Facebook - which means it's accessible to users wherever there's a browser and an internet connection: main or branch practice, home or out in the field. Log in from anywhere and you'll always see the same data.
"Practice data is held securely at a remote location and, with automatic back-up systems, some of the biggest worries about onsite IT systems - theft, fire, flooding and protection from computer viruses - are removed immediately.
"In the event of system maintenance or issues, customers talk to a friendly, UK-based support and development team, who can access and modify the system in real time; practices won't have to wait for an engineer to attend. In fact, we have a very content practice in Oman now running the system; the installation and set-up has all been carried out from a distance."
By removing the 'IT headache', Mr Houghton says practices choosing VetIT will be able to run their businesses more effectively, while developing closer, more valuable relationships with customers.
He said: "The web-based system allows vets' customers to log-in to 'their' VetIT, where they can check records, pay bills, or place orders. Practices can also maintain and build a relationship with customers via e-mail and SMS reminders of appointments, check-ups, treatments due and so on."
As for running costs and pricing, Mr Houghton cites pre-launch studies showing the potential for productivity gains in practices deploying VetIT, while the system's clear pricing - from low-cost start-up practices to corporate licensing for multi-site operations - gives peace of mind with smooth, predictable costs through the system's life. "You don't have to buy expensive computer hardware like servers and back-up systems, and pay-as-you-go pricing eliminates up-front software licensing costs."
Mr Houghton says users in so-called 'notspots' - areas of the country where broadband connections run at less than 2Mbps or are non-existent - need not feel left out, either. "We've designed the system to be as fast as possible, with no heavy data-transfer requirements. In fact, data transfer within the system is so well optimised that it will even work with a dial-up connection or mobile broadband."
More information about VetIT is at http://www.vetit.co.uk/, or contact Nick Cole.
The new course is called ‘New staff training course with Post2Pet’, and, as the name suggests, it will look at how to incorporate the home delivery option into a preventative healthcare plan.
Premier Vet Alliance says the course is suitable for any member of the practice team that wants to increase their knowledge about healthcare plans.
The course is 4 modules long with an assessment leading to 1.5 hours of completed CPD. It will launch towards the end of April.
James Tudor, Head of Customer Experience at Premier Vet Alliance, said: "This is a fantastic resource and I am I so proud of the team who’ve developed this and helped practices to train staff efficiently and effectively.
"It’s opening up the future of training and we hope to gain guidance in developing our training provision by working directly with practices, to help keep the training relevant.
"We see real value in CPD accredited courses, especially where they help enable veterinary staff to increase their knowledge on maximising their clients’ compliance. They can also learn how to influence animal health, and drive other aspects of the business through health plans."
"This is just the beginning; we will continue to increase our CPD accreditations and share best practice across Europe and the United States."
For more information contact 0117 370 0300 or email pcp@premiervetalliance.co.uk .
For the research, Purina questioned 1535 current and potential dog owners using validated scales assessing depression, anxiety, happiness, attitude and commitment toward their pet, and perceived social support.
67% of participants said they felt that COVID had had an emotional impact on them.
One-third of participants also felt that their health had been impacted by the pandemic, while 45% had experienced a financial impact.
However, it was found that dog owners had higher perceived level of social support and lower depression scores.
Francois Martin, M.A., Ph.D., applied behaviour and welfare research section leader at Purina and lead Purina scientist on the project said: "Our research showed that dog owners fared better from a social support and emotional standpoint during COVID than people who like dogs but didn’t own one during the pandemic.
"Our work adds to a growing body of evidence demonstrating the power of the human pet bond, especially in times of stress.”
Libby Sheridan MVB MRCVS, Purina Scientific Affairs Manager for the UK and Ireland said: "The research aimed to build on prior evidence that suggests that dogs can contribute to their owner’s positive affective state - a psychological term describing when people are in generally positive frame of mind like excited, enthusiastic, and inspired.
"Purina also set out to gain a better understanding of whether the power of the pet-owner bond continued to persist during the pandemic. Not only was the effect of dogs shown to be positive, it was also measurable and statistically significant.”
Purina says the results also provide an opportunity to reflect on the important contribution of veterinary professionals, many of whom continued to work throughout the pandemic to provide much needed services.
For full results, visit: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0260676
Lanes Health, manufacturer of the mobility supplement, LitoVet, has announced the nominees for the inaugural Litovet Equine Scientific Achievement Award, part of the annual Animal Health Trust (AHT) awards.
The award which has been set up to recognise a person or group whose clinical or scientific work has made a substantial difference to the equine veterinary world will be judged by a panel of leading veterinary surgeons and scientists.
The nominees are:
Peter Clegg - MA VerMB PhD CertsES DepEVCS MRCVS. Dr Clegg is Professor of Equine Surgery and Deputy Head of the Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, The University of Liverpool. Peter's current research focus is equine orthopaedics, in particular identifying the basic mechanisms of injury and repair in equine joints and tendons. He has supervised 13 successful PhD students and is currently supervising a further nine.
Andy Durham BSc, BVSc, DEIM, Dipl.ECEIM, MRCVS (RCVS & European Specialist in equine internal medicine). Liphook-based Andy Durham exemplifies the premise that veterinarians in practice can maintain an active interest in current research, undertake clinically relevant research projects, interact with researchers on an international stage and contribute to CPD through scientific papers, book chapters and lectures.
Tim Mair BVSc PhD DEIM DESTS DipECEIM MRCVS. Dr Mair ha been innovative in veterinary practice (e.g., an early adopter of standing magnetic resonance imaging [MRI]), has an extensive publication list recently focusing on evidence-based medicine for colic, but spanning the full breadth of common medical disorders in horses. He has made an enormous contribution to veterinary practice within both Europe and America in his role as Editor of Equine Veterinary Education.
Chris Proudman MA VetMB PhD CertEO FRCVS.Dr Proudman is Professor of Equine Studies at the University of Liverpool. His research interests are related to the aetiology and surgical management of acute intestinal disease (colic) in the horse: specifically, the diagnosis of intestinal parasites associated with colic and understanding dietary determinants of colic. Most recently this has involved using metabolomics and molecular microbiology to investigating the intestinal microbiota and its response to dietary change.
The LitoVet Equine Scientific Achievement Award can be granted to any individual or group that is currently undertaking, or has successfully implemented within the past ten years, one or more clinical or other research projects which has, or will, make a significant contribution to equine health and welfare.
The award will be presented to the recipient, or recipients, at the UK Equestrian Awards held at the Lancaster London on Thursday 3 November 2011.